Archive for November 2017

Myomo Expands MyoPro® Centers of Excellence Program

Growing Nationwide Roster Supports MyoPro Powered Orthosis Cambridge, MA., November 29, 2017 – Myomo, Inc. (NSYE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics (O&P) locations to its Center of Excellence (CoE) program, which recognizes top O&P practices that support the…

Read More

Myomo, Inc. to Present at the 10th Annual LD Micro Main Event

CAMBRIDGE, Mass., November 28, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5th at 9:30 AM PST / 12:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.  Chairman and Chief…

Read More

Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering

CAMBRIDGE, Mass., November 13, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase…

Read More

Myomo, Inc. Issues November 2017 Shareholder Letter

CAMBRIDGE, Mass., November 7, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities. Read more.

Read More

Myomo, Inc. Reports Third Quarter 2017 Results

CAMBRIDGE, Mass., November 6, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and nine months ended September 30, 2017. Read more.

Read More

Myomo Enters Canadian Market

Ottobock to Distribute MyoPro® to Orthotics and Prosthetics Practices Throughout Country CAMBRIDGE, Mass., November 03, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its…

Read More